Drug Type CAR-T |
Synonyms- |
Target |
Action inhibitors, stimulants |
Mechanism CLL-1 inhibitors(C-Type lectin domain family 12 member A inhibitors), IL-18 stimulants(Interleukin 18 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Myeloid Leukemia | Preclinical | China | 16 Nov 2025 |





